Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

H. Schrader

BMJ · 2001 · 287 citations · 13 references

DOIFull text

Open access

Abstract

The angiotensin converting enzyme inhibitor, lisinopril, has a clinically important prophylactic effect in migraine.

References

13